UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis

PloS one, 2019-12, Vol.14 (12), p.e0226043-e0226043

2019

Link zum Volltext

Verfügbarkeit prüfen

Chronic nonbacterial osteomyelitis — clinical and magnetic resonance imaging features

Pediatric radiology, 2021-02, Vol.51 (2), p.282-288

2021

Link zum Volltext

Verfügbarkeit prüfen

Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial

Arthritis & rheumatology (Hoboken, N.J.), 2015-03, Vol.67 (3), p.840-848

2015

Link zum Volltext

Verfügbarkeit prüfen

Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma

Frontiers in immunology, 2021-03, Vol.12, p.663329-663329

2021

Link zum Volltext

Verfügbarkeit prüfen

Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach

Pediatric rheumatology online journal, 2017-12, Vol.15 (1), p.87-87, Article 87

2017

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus

Pediatric rheumatology online journal, 2021-09, Vol.19 (1), p.144-144, Article 144

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis

Pediatric rheumatology online journal, 2021-08, Vol.19 (1), p.123-123, Article 123

2021

Link zum Volltext

Verfügbarkeit prüfen

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

Pediatric rheumatology online journal, 2019-05, Vol.17 (1), p.25-25, Article 25

2019

Link zum Volltext

Verfügbarkeit prüfen

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Frontiers in pharmacology, 2019-01, Vol.9, p.1526-1526

2019

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)

Pediatric rheumatology online journal, 2020-07, Vol.18 (1), p.55-55, Article 55

2020

Link zum Volltext

Verfügbarkeit prüfen

Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies

Best practice & research. Clinical rheumatology, 2017-08, Vol.31 (4), p.505-516

2017

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic stunned myocardium presenting as left ventricular hypertrabeculation in childhood: A variant of Takotsubo cardiomyopathy?

Pediatric critical care medicine, 2011-11, Vol.12 (6), p.e420-e423

2011

Link zum Volltext

Verfügbarkeit prüfen

It is about time: the first validated biomarker for early diagnosis of systemic juvenile idiopathic arthritis

Rheumatology (Oxford, England), 2022-07, Vol.61 (7), p.2724-2725

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Treatment and IL1RN Single‐Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-06, Vol.73 (6), p.1053-1061

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of emapalumab in macrophage activation syndrome

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.857

2023

Link zum Volltext

Verfügbarkeit prüfen

Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis

Journal of rheumatology, 2017-08, Vol.44 (8), p.1231

2017

Link zum Volltext

Verfügbarkeit prüfen

Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience

Journal of rheumatology, 2015-08, Vol.42 (8), p.1523

2015

Link zum Volltext

Verfügbarkeit prüfen

Microbiota transplant to control inflammation in a patient with NLRC4 gain-of-function–induced disease

Journal of allergy and clinical immunology, 2023-07, Vol.152 (1), p.302-303

2023

Link zum Volltext

Verfügbarkeit prüfen

Expansion of CD4dimCD8+T cells characterizes macrophage activation syndrome and other secondary HLH

Blood, 2022-07, Vol.140 (3), p.262-273

2022

Link zum Volltext

Verfügbarkeit prüfen

A patient with stimulator of interferon genes–associated vasculopathy with onset in infancy without skin vasculopathy

Rheumatology (Oxford, England), 2020-04, Vol.59 (4), p.905-907

2020

Link zum Volltext

Verfügbarkeit prüfen

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

Arthritis and rheumatism, 2011-02, Vol.63 (2), p.545-555

2011

Link zum Volltext

Verfügbarkeit prüfen

It is about time: the first validated biomarker for early diagnosis of sJIA

Rheumatology (Oxford, England), 2021-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody

Blood, 2021-11, Vol.138 (Supplement 1), p.2058-2058

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(52)
Berichte
(1)

Sprache

Englisch
(53)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(37)
Rheumatology
(28)
Female
(26)
Male
(21)
Child
(20)
Pediatrics
(14)
Adolescent
(12)
Child, Preschool
(12)
Treatment Outcome
(9)
Arthritis
(8)
Arthritis, Juvenile - Drug Therapy
(8)
Infant
(8)
Inflammation
(7)
Patients
(6)
Retrospective Studies
(6)
Severity Of Illness Index
(6)
Systemic Juvenile Idiopathic Arthritis
(6)
Anakinra
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis

Chronic nonbacterial osteomyelitis — clinical and magnetic resonance imaging features

Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial

Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma

Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach

Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus

Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)

Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies

Neurogenic stunned myocardium presenting as left ventricular hypertrabeculation in childhood: A variant of Takotsubo cardiomyopathy?

It is about time: the first validated biomarker for early diagnosis of systemic juvenile idiopathic arthritis

ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study

Early Treatment and IL1RN Single‐Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic Arthritis

Efficacy and safety of emapalumab in macrophage activation syndrome

Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis

Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience

Microbiota transplant to control inflammation in a patient with NLRC4 gain-of-function–induced disease

Expansion of CD4dimCD8+T cells characterizes macrophage activation syndrome and other secondary HLH

A patient with stimulator of interferon genes–associated vasculopathy with onset in infancy without skin vasculopathy

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

It is about time: the first validated biomarker for early diagnosis of sJIA

Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody

Suchergebnisse filtern